MarketScreener Strategies LENZ Therapeutics, Inc. OTC Markets
Equities
GRPH
US52635N1037
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
16.4 USD | -26.35% | -4.79% | +21.37% |
Apr. 15 | Leerink Partners Starts LENZ Therapeutics With Outperform Rating, $32 Price Target | MT |
Apr. 15 | William Blair Starts LENZ Therapeutics With Outperform Rating | MT |
- Stock Market
- Equities
- LENZ Stock
- GRPH Stock
- News LENZ Therapeutics, Inc.
- MarketScreener Strategies